BioBusiness 2012
January 31 - February 2, 2012
london , United Kingdom
BioBusiness 2012 - The leading high-level BioPharma strategy and bio-partnering conference
This leading bio-partnering conference is THE only place in London where VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers behind innovation will gather to discuss high level strategy and build relationships. Forward thinking companies will come to make their next big deal.
We've listened to our delegates and BioBusiness 2012 returns to London in January with a revamped, strategically focused programme and speaker cohort based on your industry feedback
A biopharma strategy and bio-partnering conference that provides unique networking opportunities and sessions focused on providing true value
We’ve listened and, alongside an advisory board of industry leaders, have created an event that breaks down the barriers between speakers and delegates. The event provides an interactive and networking friendly environment where innovation is encouraged and commentary incisive and relevant.
The strongly content driven agenda is designed to provide true insight and focuses on key outcomes, case studies outlining what works (and importantly, what did not) along with the paradigm shifts in strategy that occurred as a result.
Bio-partnering event produced for the industry, by the industry – meet the BioBusiness 2012 advisory panel
Denise Goode
Executive Transaction Director, Strategic Planning and Business Development
AstraZeneca
Steven Holtzman
EVP Corporate Development
Biogen Idec
Martino Picardo
Chief Executive Officer
Stevenage Bioscience Catalyst
Simon Haworth
Managing Director
BSG Team Ventures
This leading bio-partnering conference is THE only place in London where VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers behind innovation will gather to discuss high level strategy and build relationships. Forward thinking companies will come to make their next big deal.
We've listened to our delegates and BioBusiness 2012 returns to London in January with a revamped, strategically focused programme and speaker cohort based on your industry feedback
A biopharma strategy and bio-partnering conference that provides unique networking opportunities and sessions focused on providing true value
We’ve listened and, alongside an advisory board of industry leaders, have created an event that breaks down the barriers between speakers and delegates. The event provides an interactive and networking friendly environment where innovation is encouraged and commentary incisive and relevant.
The strongly content driven agenda is designed to provide true insight and focuses on key outcomes, case studies outlining what works (and importantly, what did not) along with the paradigm shifts in strategy that occurred as a result.
Bio-partnering event produced for the industry, by the industry – meet the BioBusiness 2012 advisory panel
Denise Goode
Executive Transaction Director, Strategic Planning and Business Development
AstraZeneca
Steven Holtzman
EVP Corporate Development
Biogen Idec
Martino Picardo
Chief Executive Officer
Stevenage Bioscience Catalyst
Simon Haworth
Managing Director
BSG Team Ventures
Related events
BioBusiness 4 February, 2015
BioBusiness 4 February, 2014
BioBusiness 4 February, 2013
BioBusiness January 31 - February 2, 2012
BioBusiness January 19 - 20, 2011
